Skip to main content
. 2012 Jun 16;32(5):507–517. doi: 10.1007/s10792-012-9589-2

Fig. 3.

Fig. 3

Resolution of cells and flare in clinical studies of loteprednol etabonate 0.5 %, rimexolone 1 %, and difluprednate 0.5 % for postoperative inflammation following uncomplicated cataract surgery. Resolution of cells and flare was defined as ≤5 cells and none-to-trace flare in loteprednol etabonate and rimexolone studies and <5 cells and no flare in difluprednate studies